PRESS RELEASE
Billingham, UK/Camelford, UK – 27th May 2014: Cambridge Research Biochemicals (“CRB”) and Key Organics Limited (“Key Organics”) today announced that they have entered into an exclusive supply & marketing agreement.
Since CRB was established in 1980, the Company quickly became a global leader in the supply of custom–made peptides and has recently expanded its premises in Billingham, UK. CRB continues to develop the range of products and services offered and can supply all flavours of peptides. This encompasses simple to heavily modified targets and various labels including stable-isotopes, radio-isotopes and fluorescent dyes can be incorporated. Milligram to gram-scale quantities are offered at the highest levels of purity.
Within its BIONET brand, Key Organics offers an extensive range of over 74,000 screening compounds, intermediates, building blocks and biochemicals to the international pharmaceutical, biotechnology and agrochemical industries. With new premises near Boston, USA, Key Organics is able to supply its BIONET products to the North American market.
As an innovator within the peptide industry, CRB wishes to expand the market range of its growing peptide product portfolio. Key Organics has access to a global customer base within the life sciences sector, excellent customer service and compound handling infrastructure that ensures that products are dispatched on the same day. The alliance will allow both companies to offer an increasing range of products to a wider market audience.
Emily Humphrys, Commercial Director at CRB commented: “Our partnership with Key Organics will allow us to access the catalogue peptide market, which we have not served since the early nineties. We will continue to focus on our core peptide activities, serving our key customers with bespoke custom-made peptides, whilst Key Organics sells our new catalogue peptide range.”
Joe Carey, Managing Director at Key Organics commented: “We have been seeking to extend our product range in the peptide area so are delighted to enter into this agreement with CRB. The Company has established itself as a world leader in peptide chemistry with an excellent quality and service record that conforms to the standards we have established for our BIONET portfolio”.
The agreement between the parties provides for the exclusive, global supply of CRB’s products by Key Organics.
For more information, please contact:
Key Organics:
Dr Joe Carey, Managing Director
Cambridge Research Biochemicals:
Emily Humphrys, Commercial Director
About Key Organics
Key Organics, part of the Tennant Group of Companies, is a leading supplier of R&D compounds and chemistry contract research services to the international life sciences industries. Through its BIONET product brand, Key Organics is able to directly offer over 74,000 intermediates, fragments, biochemicals and screening compounds with same day dispatch.
More information can be found at: www.keyorganics.net, e-mail [email protected]
About CRB
Cambridge Research Biochemicals is a leading independent producer of custom-made peptide and antibody tools, supplying researchers in the pharmaceutical, life science and academic sectors worldwide. The company produces a wide and varied selection of bespoke peptides and also offers both polyclonal and monoclonal antibody generation programmes. CRB also distributes supporting products such as PNA and Europium chelate.
To learn more about CRB please visit http://www.crbdiscovery.com, e-mail [email protected]
